Physician profile
Muhammad S Sadiq
NPI 1083920813
$1,920.14
in general payments reported to CMS, 2019-2025
16 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.90 · 2020: $11.41 · 2021: $348 · 2022: $559 · 2023: $374 · 2024: $256 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $729.10 | 2019-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $223.76 | 2021-2025 | Ultomiris, Soliris |
| Merck Sharp & Dohme LLC | $171.40 | 2020-2024 | Verquvo, Dificid |
| Abbott Laboratories | $165.56 | 2025 | Triclip |
| Pfizer INC. | $143.84 | 2019-2024 | |
| Gilead Sciences, INC. | $106.21 | 2023-2024 | Veklury |
| Novartis Pharmaceuticals Corporation | $72.08 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $66.91 | 2024-2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.48 | 2022-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.81 | 2022 | |
| Fisher & Paykel Healthcare INC | $37.43 | 2021 | |
| Shire North American Group INC | $23.20 | 2019 | |
| Shionogi INC | $22.19 | 2023 | Fetroja |
| Vertex Pharmaceuticals Incorporated | $20.84 | 2025 | |
| Vifor Pharma, INC. | $16.57 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Sadiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.